46 related articles for article (PubMed ID: 35167707)
1. Long-Term Efficacy and Safety of Omalizumab Monotherapy in a Patient With Normocomplementemic Urticarial Vasculitis.
Abuzakouk M; Ghorab O; Namas R; Maurer M
J Drugs Dermatol; 2022 Oct; 21(10):1124-1126. PubMed ID: 36219045
[TBL] [Abstract][Full Text] [Related]
2. Hypocomplementemic Urticarial Vasculitis Syndrome.
Umemoto D; Nishioka H
J Clin Rheumatol; 2023 Apr; 29(3):e15-e16. PubMed ID: 36959201
[No Abstract] [Full Text] [Related]
3. COVID-19 in a patient with hypocomplementemic urticarial syndrome and MPO-ANCA vasculitis on hemodialysis treated with omalizumab.
Baldallo C; León Román JC; Seron D; Agraz I; Solans R; Ramos N; Soler MJ
Nefrologia (Engl Ed); 2021; 41(3):354-355. PubMed ID: 36166252
[No Abstract] [Full Text] [Related]
4. Hypocomplementemic Urticarial Vasculitis Syndrome with Crescentic Glomerulonephritis.
Nouha BM; Meriem BS; Khaled TS; Manel BS; Insaf H; Mouna H; Ahmed L; Sabra A; Abdelfatteh Z; Habib S
Indian J Pediatr; 2023 Jan; 90(1):102. PubMed ID: 36447067
[No Abstract] [Full Text] [Related]
5. IgA vasculitis.
Tadokoro T; Abe T; Nakano T; Kimura Y; Higaki K; Hayashidani S; Tashiro H
QJM; 2023 Jul; 116(7):538-539. PubMed ID: 36912689
[No Abstract] [Full Text] [Related]
6. Urticarial vasculitis.
Chang S; Carr W
Allergy Asthma Proc; 2007; 28(1):97-100. PubMed ID: 17390766
[TBL] [Abstract][Full Text] [Related]
7. Urticarial Vasculitis Successfully Treated With Omalizumab.
Ermertcan AT; Aktaş A; Öztürk F; Temiz P
Cutis; 2021 May; 107(5):E19-E21. PubMed ID: 34288864
[No Abstract] [Full Text] [Related]
8. Use of omalizumab in the treatment of hypocomplementemic urticarial vasculitis.
Navarro-Navarro I; Jiménez-Gallo D; Villegas-Romero I; Linares-Barrios M
Dermatol Ther; 2020 Mar; 33(2):e13237. PubMed ID: 32012397
[No Abstract] [Full Text] [Related]
9. Successful treatment of urticarial vasculitis with omalizumab in children: a case series.
Wang S; Fu L; Xiang X; Zhang B; Ma L; Xing H
Clin Exp Dermatol; 2023 Sep; 48(10):1145-1148. PubMed ID: 37227921
[TBL] [Abstract][Full Text] [Related]
10. Patient-reported outcomes in urticarial vasculitis treated with omalizumab: case report.
Cherrez-Ojeda I; Vanegas E; Felix M; Mata VL; Cherrez A
BMC Dermatol; 2018 Oct; 18(1):8. PubMed ID: 30359231
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of normocomplementemic urticarial vasculitis with omalizumab: A report of three cases and literature review.
Rattananukrom T; Svetvilas P; Chanprapaph K
Asian Pac J Allergy Immunol; 2020 Dec; 38(4):286-289. PubMed ID: 30660172
[TBL] [Abstract][Full Text] [Related]
12. Cold urticarial vasculitis successfully treated with omalizumab.
Ayén-Rodríguez A; Llamas-Molina JM; Gálvez-Moreno M; Ruiz-Villaverde R
Int J Dermatol; 2023 Feb; 62(2):e77-e78. PubMed ID: 35167707
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
